Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
Hong Kong · Delayed Price · Currency is HKD 15.91
-0.14 (-0.87%)
Jul 9, 2026, 4:08 PM HKT
HKG:6826 Market Cap
HKG:6826 has a market cap or net worth of 7.26 billion as of July 9, 2026. Its market cap has decreased by -38.18% in one year.
Market Cap
7.26B
Enterprise Value
5.17B
Revenue
2.73B
Ranking
n/a
PE Ratio
13.83
Stock Price
15.91
Market Cap Chart
Since April 30, 2015, HKG:6826's market cap has decreased from 9.34B to 7.26B, a decrease of -22.27%. That is a compound annual growth rate of -2.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 7.26B | -28.62% |
| Dec 31, 2025 | 10.17B | -23.81% |
| Dec 31, 2024 | 13.35B | -24.15% |
| Dec 29, 2023 | 17.60B | 7.10% |
| Dec 30, 2022 | 16.43B | -29.33% |
| Dec 31, 2021 | 23.25B | 40.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HBM Holdings | 9.92B |
| Everest Medicines | 9.62B |
| CARsgen Therapeutics Holdings | 9.10B |
| Suzhou Ribo Life Science | 8.85B |
| CStone Pharmaceuticals | 8.55B |
| Abbisko Cayman | 8.13B |
| LongBio Pharma (Suzhou) | 8.02B |
| Lepu Biopharma | 7.76B |